Jemperli

Merck
Pharma

Merck touts Keytruda front-line win in endometrial cancer subtype

The news follows Merck's recent positive endometrial cancer readout from the first global phase 3 trial of its Kelun-Biotech-partnered sac-TMT.
Angus Liu Jul 15, 2026 3:33pm
GSK

GSK to seek FDA approval for Jemperli in high-profile cancer use

Jul 13, 2026 10:50am
law and order concept

GSK’s Tesaro can’t trim AnaptysBio's Jemperli royalties: judge

Apr 28, 2026 8:41am
GSK

GSK licenses Alteogen enzyme in bid to develop subQ Jemperli

Jan 20, 2026 2:26pm
locking horns fight battle lock horns

GSK's Tesaro, AnaptysBio lock horns over Jemperli agreement

Nov 21, 2025 9:46am
direction arrow
Favicon Fierce Biotech

Anaptys plans to split into 2 businesses

Sep 30, 2025 9:35am